Talat Imran
CEO
CEO
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Rani Therapeutics Holdings, Inc. (RANI) | Chief Executive Officer | $198,325 | $1,052,101 |
| 2024 | Rani Therapeutics Holdings, Inc. (RANI) | Chief Executive Officer | $105,818 | $3,042,245 |
| 2023 | Rani Therapeutics Holdings, Inc. (RANI) | Chief Executive Officer | $450,000 | $5,266,893 |
| 2022 | Rani Therapeutics Holdings, Inc. (RANI) | Chief Executive Officer | $515,000 | $4,311,190 |
| 2021 | Rani Therapeutics Holdings, Inc. (RANI) | Chief Executive Officer | $408,333 | $11,782,823 |
Earnings-call appearances
-
Canaccord Genuity 46th Annual Growth Conference2026-08-12
Rani Therapeutics Holdings, Inc. (RANI)
-
Rani Therapeutics Holdings, Inc. Q4 FY2025 Earnings Call2026-03-26
Rani Therapeutics Holdings, Inc. (RANI)
-
Rani Therapeutics Holdings, Inc. Q4 FY2023 Earnings Call2024-03-20
Rani Therapeutics Holdings, Inc. (RANI)
-
Rani Therapeutics Holdings, Inc. Q4 FY2022 Earnings Call2023-03-22
Rani Therapeutics Holdings, Inc. (RANI)
-
Rani Therapeutics Holdings, Inc. Q4 FY2021 Earnings Call2022-03-29
Rani Therapeutics Holdings, Inc. (RANI)